Bisacodyl phenol D8

STABLE ISOTOPES

CAT No.# CS-P-00072
Category Stable Isotopes
CAS 603-41-8 (Unlabeled)
Stock Status
AVAILABLE ENQUIRE NOW View COA

(Available within 3-5 days)

Product maybe under re-certification or re-stock. Enquire now to know exact date of delivery and pricing.
Molecular Weight 285.38
Molecular Formula C18H7NO2D8
Purity: >98%
Synonyms: 4‐{[4‐hydroxy(D4)phenyl](pyridin‐2‐ yl)methyl}(D4)phenol;Desdiacetyl Bisacodyl D8.
Application Notes: Labeled Bisacodyl metabolite , intended for use as an internal standard for the quantification of Bisacodyl metabolite by GC- or LC-mass spectrometry.
References: Schmidt, et al.: Arzneim.-Forsch., 3, 19 (1953), Wald, A., et al.: J. Clin. Gastroenterol., 36, 386 (2003),
Shipping: Free Shipping for worldwide on order above 2000 USD
Bisacodyl phenol D8 Worldwide Suppliers of Bisacodyl phenol D8 Stable Isotopes Clearsynth CS-P-00072

Product rating: 9 Bisacodyl phenol D8 based on 20 ratings

  1. Stable Isotopes
  2. Bisacodyl phenol D8


PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Riluzole (1604337)
15. Pheniramine impurity B
16. Palbociclib N-Glucuronide
17. Carpropamid
18. Olmesartan N1-Trityl Impurity
19. Aripiprazole (1042634)
20. 2-(p-Tolyl)pyrimidine
Smileys:
OC1=C([2H])C([2H])=C(C([2H])=C1[2H])C(C2=CC=CC=N2)C(C([2H])=C3[2H])=C(C([2H])=C3O)[2H]



This page contains information about Bisacodyl phenol D8 Cas 603-41-8 (Unlabeled) and its Stable Isotopes.

Bisacodyl phenol D8 Bisacodyl phenol D8 Worldwide Suppliers of Bisacodyl phenol D8 Stable Isotopes Clearsynth 603-41-8 (Unlabeled)

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."